⌘K

08:53:10·1173d

13D/GFilingvia Quantisnow

SEC Form SC 13G/A filed by Sio Gene Therapies Inc. (Amendment)

ByQuantisnow·Wall Street's wire, on your screen.

SIOX· Sio Gene Therapies Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

SIOX
Sio Gene Therapies Inc.
Health Care

Recent analyst ratings

Feb 1UpdateHC Wainwright & Co.$7.00
Feb 1UpdateSVB Leerink$1.00
Oct 21UpdateHC Wainwright & Co.$10.00
Aug 12UpdateSVB Leerink$6.00
Jul 12UpdateChardan Capital Markets$12.50

Related

PR819d
Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
SEC1102d
SEC Form 15-12G filed by Sio Gene Therapies Inc.
SEC1103d
SEC Form EFFECT filed by Sio Gene Therapies Inc.
SEC1110d
SEC Form POS AM filed by Sio Gene Therapies Inc.
SEC1110d
SEC Form S-8 POS filed by Sio Gene Therapies Inc.
SEC1115d
SEC Form 25-NSE filed by Sio Gene Therapies Inc.
SEC1121d
SEC Form 25 filed by Sio Gene Therapies Inc.
SEC1121d
Sio Gene Therapies Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders